Scoliosis Treatment Research Report with Outlook, Strategies, Challenges, Geography Trends
Scoliosis causes the spine to curve to one side and can
affect any part of the spine, but the most commonly affected areas are at the
level of the chest and the lower back. The scoliosis treatment market is driven
by various factors such as the increasing prevalence of scoliosis surgeries,
increasing demand for spine surgeries, the high adoption rate of braces, and
the growing prevalence of musculoskeletal disorders. However, the high cost of
treatment or procedures and limited understanding of the disorder and available
treatment options are expected to curb the growth of the scoliosis treatment
market.
It is estimated that the global scoliosis
treatment market is expected to register a CAGR of~ 3.9% during the
forecast period of 2019 to 2025, with a market value of USD 2,580.2 million in
2018. The global scoliosis treatment market is currently dominated by numerous
market players. The key players are involved in product launches and strategic
collaborations to strengthen its market position. For instance, in July 2018,
NuVasive Launched MAGEC X for early-onset scoliosis treatment. The latest
advancement of MAGEC delivers improved rod strength together with internal rod
mechanism advancements.
Request
Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8230
Key Players
Some of the key players in the global scoliosis treatment
market are NuVasive, Spinal Technology, Inc., C H Martin Company, Aspen Medical
Products, Lawall Prosthetics and Orthotics, SPINEFORM LLC, Össur, Orthotech,
Chaneco, Boston Orthotics & Prosthetics, Charleston Bending Brace, Trulife,
DJO, Wilmington Orthotics & Prosthetics, Inc., Horton's Orthotics &
Prosthetics, UNYQ, Optec USA, Inc., and Zimmer Biomet Holdings Inc.
Segmentation
The global scoliosis treatment market has been segmented
based on disease, product and distribution channel. The market, based on
disease, has been further divided into infantile idiopathic scoliosis and
adolescent idiopathic scoliosis. The adolescent idiopathic scoliosis segment is
likely to hold a major share in the market due to the increasing prevalence of
scoliosis in the adults majorly. The product segment has been segmented into
cervical thoracic lumbar sacral orthosis (CTLSO), thoracolumbosacral orthosis
(TLSO), and lumbosacral orthosis (LSO). The cervical thoracic lumbar sacral
orthosis (CTLSO) is predicted to be the fastest-growing due to increasing
demand for spine surgeries. The distribution channel segment has been
categorized as hospitals & clinics, retail pharmacies, and online
pharmacies.
Regional Analysis
Based on region, the market can be divided into the
Americas, Europe, Asia-Pacific, and the Middle East & Africa. The scoliosis
treatment market in the Americas has further been segmented into Latin America
and North America, with the North American market further sub-segmented into
the US and Canada. The European scoliosis treatment market has been sub-divided
Western Europe and Eastern Europe. Western Europe has further been divided as
France, Germany, the UK, Spain, Italy, and the rest of Western Europe. The
scoliosis treatment market in Asia-Pacific has been bifurcated into Australia,
China, Japan, India, South Korea, and the rest of Asia-Pacific. The scoliosis
treatment market in the Middle East & Africa has been segmented into the
Middle East and Africa.
Browse Detailed TOC
with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/scoliosis-treatment-market-8230
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Comments
Post a Comment